Julie Charton

1.7k total citations · 1 hit paper
43 papers, 1.1k citations indexed

About

Julie Charton is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, Julie Charton has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Organic Chemistry and 10 papers in Spectroscopy. Recurrent topics in Julie Charton's work include Analytical Chemistry and Chromatography (10 papers), Microfluidic and Capillary Electrophoresis Applications (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Julie Charton is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Microfluidic and Capillary Electrophoresis Applications (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Julie Charton collaborates with scholars based in France, Belgium and United States. Julie Charton's co-authors include Benoît Déprez, Rebecca Deprez‐Poulain, Bart Staels, Christian Sergheraert, Anne Tailleux, Boudewijn Brans, Emmani B. M. Nascimento, Felix M. Mottaghy, Mostafa Kouach and Patrick Schrauwen and has published in prestigious journals such as Angewandte Chemie International Edition, Cell Metabolism and Analytical Biochemistry.

In The Last Decade

Julie Charton

42 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity

2015 343 citations Evie P. M. Broeders, Emmani B. M. Nascimento et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Charton France	17	472	276	228	205	199	43	1.1k
Erika Roat Italy	19	754 1.6×	149 0.5×	103 0.5×	133 0.6×	160 0.8×	26	1.6k
Lawrence F. Colwell United States	19	555 1.2×	398 1.4×	106 0.5×	129 0.6×	98 0.5×	33	1.2k
Dennis Dean United States	25	614 1.3×	571 2.1×	88 0.4×	381 1.9×	100 0.5×	66	2.0k
Marta Menicatti Italy	17	506 1.1×	156 0.6×	115 0.5×	71 0.3×	74 0.4×	33	809
Benjamin M. Johnson United States	19	586 1.2×	407 1.5×	77 0.3×	84 0.4×	66 0.3×	41	1.5k
Ruchika Sharma India	23	660 1.4×	124 0.4×	44 0.2×	275 1.3×	117 0.6×	83	1.4k
Shigeo Ikegawa Japan	19	556 1.2×	103 0.4×	92 0.4×	444 2.2×	71 0.4×	97	1.3k
Anil Nilkanth Gaikwad India	27	675 1.4×	656 2.4×	246 1.1×	63 0.3×	293 1.5×	65	1.7k
Teruki Yoshimura Japan	22	460 1.0×	129 0.5×	47 0.2×	129 0.6×	66 0.3×	73	1.1k
Amy Q. Wang United States	17	390 0.8×	110 0.4×	34 0.1×	225 1.1×	148 0.7×	31	1.1k

Countries citing papers authored by Julie Charton

Since Specialization

Citations

This map shows the geographic impact of Julie Charton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Charton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Charton more than expected).

Fields of papers citing papers by Julie Charton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Charton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Charton. The network helps show where Julie Charton may publish in the future.

Co-authorship network of co-authors of Julie Charton

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Charton. A scholar is included among the top collaborators of Julie Charton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Charton. Julie Charton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Furman, Christophe, et al.. (2024). Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors. Electrophoresis. 45(11-12). 1010–1017.

2.

Landry, Valérie, Lowiese Desmarets, François‐Xavier Cantrelle, et al.. (2024). N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease. European Journal of Medicinal Chemistry. 276. 116707–116707. 1 indexed citations

3.

Dumont, Julie, Virginie Vauthier, Julie Charton, et al.. (2024). Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach. Communications Biology. 7(1). 898–898. 1 indexed citations

4.

Hanoulle, Xavier, Valérie Landry, Danai Moschidi, et al.. (2023). Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses. European Journal of Medicinal Chemistry. 250. 115186–115186. 12 indexed citations

5.

Charton, Julie, et al.. (2021). Supercritical fluid chromatography and liquid chromatography for isomeric separation of a multiple chiral centers analyte. Journal of Chromatography A. 1651. 462270–462270. 13 indexed citations

6.

Wen, Xiaoan, Valérie Landry, Adrien Herlédan, et al.. (2021). Identification of indole-based activators of insulin degrading enzyme. European Journal of Medicinal Chemistry. 228. 113982–113982. 7 indexed citations

7.

Cantrelle, François‐Xavier, Emmanuelle Boll, Danai Moschidi, et al.. (2021). NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment. Angewandte Chemie International Edition. 60(48). 25428–25435. 30 indexed citations

8.

Cantrelle, François‐Xavier, Emmanuelle Boll, Danai Moschidi, et al.. (2021). NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment. Angewandte Chemie. 133(48). 25632–25639. 1 indexed citations

9.

Leroux, Florence, Damien Bosc, Terence Beghyn, et al.. (2019). Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European Journal of Medicinal Chemistry. 179. 557–566. 13 indexed citations

10.

Charton, Julie, et al.. (2018). Application of tandem coupling of columns in supercritical fluid chromatography for stereoisomeric separation: Optimization and simulation. Journal of Chromatography A. 1588. 115–126. 17 indexed citations

11.

Broeders, Evie P. M., Emmani B. M. Nascimento, Bas Havekes, et al.. (2015). The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Cell Metabolism. 22(3). 418–426. 343 indexed citations breakdown →

12.

Henninot, Antoine, et al.. (2015). Characterization of monoclonal antibodies by a fast and easy liquid chromatography–mass spectrometry time-of-flight analysis on culture supernatant. Analytical Biochemistry. 491. 52–54. 12 indexed citations

13.

Lipka, Emmanuelle, et al.. (2010). Determination of pKa values of benzimidazole derivatives from mobility obtained by capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 53(5). 1267–1271. 11 indexed citations

14.

Groseth, Allison, Julie Charton, Markus Sauerborn, et al.. (2008). The Ebola virus ribonucleoprotein complex: A novel VP30–L interaction identified. Virus Research. 140(1-2). 8–14. 70 indexed citations

15.

Charton, Julie, et al.. (2008). Preparative enantiomeric separation of potent AMP-activated protein kinase activator by HPLC on amylose-based chiral stationary phase. Journal of Pharmaceutical and Biomedical Analysis. 46(5). 920–928. 8 indexed citations

16.

Charton, Julie, Lise Charruault, Rebecca Deprez‐Poulain, & Benoît Déprez. (2008). Alkylsquarates as Key Intermediates for the Rapid Preparation of Original Drug-Inspired Compounds. Combinatorial Chemistry & High Throughput Screening. 11(4). 294–303. 5 indexed citations

17.

Flipo, Marion, Terence Beghyn, Julie Charton, et al.. (2006). A library of novel hydroxamic acids targeting the metallo-protease family: Design, parallel synthesis and screening. Bioorganic & Medicinal Chemistry. 15(1). 63–76. 29 indexed citations

18.

Charton, Julie, et al.. (2006). Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators. Bioorganic & Medicinal Chemistry. 14(13). 4490–4518. 59 indexed citations

19.

Cazenave‐Gassiot, Amaury, et al.. (2005). Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective σ1 ligands. Part 2. Bioorganic & Medicinal Chemistry Letters. 15(21). 4828–4832. 14 indexed citations

20.

Charton, Julie, et al.. (2005). Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective σ1 ligands. Part 1. Bioorganic & Medicinal Chemistry Letters. 15(21). 4833–4837. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact